HCV in Women: Updated Guidance on Screening and Management

In this educational module, CCO’s expert faculty reviews how rising rates of HCV infection in young women have led to updated guidance on screening during pregnancy and for all individuals in the United States. 

Tatyana Kushner, MD, MSCE Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ ABIM MOC: maximum of 1.0 Medical Knowledge MOC point(s) Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Released: December 1, 2020 Expired: November 30, 2021

In this downloadable slideset, CCO’s expert faculty reviews how changes in the epidemiology of HCV infection have led to updated guidance on screening during pregnancy and for all individuals in the United States and provides insights on guidelines for HCV care in women, including during pregnancy.

Tatyana Kushner, MD, MSCE Released: January 8, 2021

Universal HCV testing in pregnant women has the potential to identify many young women and their infants, allowing for earlier treatment and prevention of long-term consequences of HCV liver disease.

Tatyana Kushner, MD, MSCE Released: December 14, 2020

Here’s my take on the challenges associated with HCV management among women of childbearing age, including during pregnancy, and how we can move toward overcoming those challenges to better achieve HCV elimination goals.

Catherine Chappell, MD, MSc Released: December 22, 2020